Is Cassava Sciences Underestimating Their Phase 3 Clinical Trials? (October 2024)

Cassava Sciences is a clinical-stage biotechnology company developing several late-stage treatments for Alzheimer&apos;s. A friend recently heard about Cassava in the news and asked me if I had any insights based on the recent biotech data I&apos;ve been exploring. I thought it was a good opportunity